
** Shares of NovaBay Pharmaceuticals NBY.A soar 75% to $1.02 after the bell
** NBY says it has entered into a $6 million securities purchase agreement with private investor David Lazar
** Lazar has also been appointed NBY's CEO, effective immediately
** NBY says it intends to use the proceeds from the investment to pursue a strategic investment and/or an acquisition
** Company also expects to declare a special cash dividend in Q3